Presentation Information
[2-MO17-3]Effective half-life in I-131 therapy for thyroid cancer using dual-timepoint imaging
Yusuke Iizuka1、Ryota Nakashima1,2、Rihito Aizawa1、Masaaki Kajisako2、Maki Shioji2、Katsuhiko Mitsumoto2、Koji Itagaki2、Shigehito Kawase2、Takashi Mizowaki1 (1.Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan、2.Division of Clinical Radiology Service, Kyoto University Hospital)